Pancreatic Cancer Research

ResearcherMary Crowley Cancer Research CenterActive in the last 2 years

Minal A. Barve

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0009-0007-4259-7457; OpenAlex author ID A5015591858. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 2

  1. Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer. Co-author DOI 10.1038/s41591-026-04537-w↗
  2. Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2505783↗

Trials 1

  1. Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer Principal investigator NCT02340117↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alexander Starodub · 2 shared papers, 2026 · strength 0.41
  2. Wungki Park · 2 shared papers, 2026 · strength 0.41
  3. Brian Matthew Wolpin · 2 shared papers, 2026 · strength 0.41
  4. David S. Hong · 2 shared papers, 2026 · strength 0.41
  5. Ignacio Garrido‐Laguna · 2 shared papers, 2026 · strength 0.41
  6. Alexander I. Spira · 2 shared papers, 2026 · strength 0.41
  7. Joel Randolph Hecht · 1 shared paper, 2026 · strength 0.23
  8. Nilofer Saba Azad · 1 shared paper, 2026 · strength 0.23
  9. Kyaw Lwin Aung · 1 shared paper, 2026 · strength 0.23
  10. Ashenafi Shiferaw Bulle · 1 shared paper, 2026 · strength 0.18
  11. Julien Dilly · 1 shared paper, 2026 · strength 0.18
  12. Ida Aronchik · 1 shared paper, 2026 · strength 0.18
  13. Urszula N. Wasko · 1 shared paper, 2026 · strength 0.18
  14. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.18
  15. Kian‐Huat Lim · 1 shared paper, 2026 · strength 0.18
  16. Anirban Maitra · 1 shared paper, 2026 · strength 0.18
  17. Mallika Singh · 1 shared paper, 2026 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.